banner add

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

November 26, 2024 0
Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

from NYT > Health https://ift.tt/pUmI5sh
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent ...

Theme images by PLAINVIEW. Powered by Blogger.